Vertex Pharmaceuticals Inc., widely recognised for its cystic fibrosis treatments, is venturing into new therapeutic areas , signalling potential growth in new markets. The company is currently advancing its development of non-opioid analgesics, specifically candidate VX-548, which has demonstrated encouraging outcomes in clinical trials. This new drug represents...
Our portfolio is up by more than 15% in the month of November. We are strictly following Mark Minervini's Trading Methodology. Here is a quick summary: Mark Minervini's trading methodology, often encapsulated in his SEPA (Specific Entry Point Analysis) system, is a comprehensive approach to trading that emphasizes the importance of timing, risk management, and...
Vertex Pharmaceuticals Inc. shares were on track for an all-time high Wednesday after the company released new data from a trial of its investigational non-opioid pain medicine. The stock jumped more than 10% Wednesday morning, on pace for its largest percentage gain in more than three years, and was set to cross the $100 billion market-capitalization threshold...
Thank you for reading this update. Depending on our study we see that VRTX has a good chance of volume increase. This updates depending on day trade, And the market should confirm with time the right market way. #Nottradingadvice
Entry: with price above 354.47 Volume: with volume greater than 2M Target: 391 area Stop: Depending on your risk tolerance; 342.3 gets you 3/1 Reward to Risk Ratio. This swing trade idea is not trade advice and is strictly based on my ideas and technical analysis. No due diligence or fundamental analysis was performed while evaluating this trade idea. Do not take...
Double bottom pattern + good earnings Looks like it can hit 396
Head & Shoulders - Looking for a break below 279.43, stop above 288.57, target 255.63 (Trading Room Alert)
A strong uptrend in solid white has formed on VRTX This trend line extends back to the 1990's It will most likely hodl and lead to further bullish continuation
Vertex Pharmaceuticals ticker symbol VRTX is in a serious uptrend. If price break above the next resistance zone around $315 before the next earnings we could see a steep rise in price. Vertex is the stock I will watching closely next week. I am going long at market prices above 283 stopout at redline 264 Happy trading.
50sma has been an important moving average for this ETF. We see 3 consecutive tests of the 50sma as resistance and a bounce lower. As we see lower highs and lower lows, the bearish trend is confirmed. I expect we fail again and test the blue line ($144.5).
Volume Profile shows virtually no volume transacted between current price and $260, so price should arrive at $260 without much trouble.
looks like is getting ready to lift up , waiting for retest #Stock #Stocks #Stockmarket
NASDAQ:VRTX had an ongoing negative Trend since July 2020. It broke the negative Trend 2 days ago. For me its a very good chance and low price for VRTX. strong up move with good volume crossing the negative trend crossed EMA200 and MA200 on daily chart and also on weeky chart still above EMA200 and MA200 on monthly chart still in positive trend since...
I like this RETEST TO PUSH HIGHER AND MAYBE FILL THE GAP THE ORANGE AREA , The risk reward is so far good
VRTX looks good value here going into earnings. Good chance of a bounce with oversold levels on daily and weekly. ** NOT TRADING OR FINANCIAL ADVICE **
All, LFMD had game changing fundamentals last quarter but still under downtrend resisance #2. This is a 3/4 retracement wave C should be ending RSI tells the story on the daily. I am watching EXTREMELY closely here. I think this is going to pop worst case is a double bottom at 7.7 or near it in which case I will absolutely be all in. Fundamnentally/valuation...
Good spot against support for VRTX LONG ** NOT TRADING ADVICE **
Chart is pretty self explanatory. Looks like we're do for a push up, watch for confirmation before jumping in.